Abstract
The formation of cytoskeletal alterations associated with abnormally phosphorylated microtubule-associated tau protein is emerging as a common pathomechanism in several neurodegenerative diseases of the human brain. These disorders include Alzheimer’s disease (AD), the most common and most extensively studied disorder associated with abnormal tau protein’. Tau pathology is also seen in other “tauopathies” including corticobasal degeneration, Pick’s disease, progressive supranuclear palsy, and argyrophilic grain disease2,3,4. These diseases are characterized by taupositive inclusions deposited not only in nerve cells but also in glial cells3,5Finally, tau pathology develops in some families afflicted with hereditary frontotemporal dementia and parkinsonism linked to chromosome 176,7. Interestingly, FTDP-17 recently has been linked to a number of pathogenetic mutations of the tau gene8. At this point, the mechanisms of tau pathology in neurons and glial cells are not fully understood Animal models replicating characteristics of human tauopathies could provide information not obtainable from studies of the human brain. In an earlier report, we demonstrated the existence of neuronal and glial tau pathology in two out of four aged baboons9. Subsequently, we extended our sample to a total of 50
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Braak E, Braak H, Mandelkow EM (1994) A sequence of cytoskeleton changes related to the formation of neurofibrillary tangles and neuropil threads. Acta Neuropathol 87: 554–567.
Braak H, Braak E (1998) Argyrophilic grain disease: frequency of occurrence in different age categories and neuropathological diagnostic criteria. J Neural Transm 105: 801–809.
Feany M.B, Mattiace, LA, Dickson DW (1996) Neuropathologic overlap of progressive supranuclear palsy, Pick’s disease and corticobasal degeneration. J Neuropathol Exp Neurol 55: 53–67.
Tolnay M, Spillantini MG, Goedert M et al. (1997) Argyrophilic grain disease: widespread hyperphosphorylation of tau protein in limbic neurons. Acta Neuropathol 93: 477–484.
Chin SSM, Goldman J (1996) Glial inclusions in CNS degenerative diseases. J Neuropathol Exp Neurol 55: 499–508.
Foster NL, Wilhelmsen K, Sima AA et al. (1997) Frontotemporal dementia and parkinsonism linked to chromosome 17: a consensus conference. Ann Neurol 41: 706–715.
Spillantini M.G, Bird TD, Ghetti B (1998) Frontotemporal dementia and Parkinsonism linked to chromosome 17: a new group of tauopathies. Brain Pathol 8: 387–402.
Hutton M, Lendon CL, Rizzu P et al. (1998) Association of missense and 5’-splice-site mutations in tau with the inherited dementia FTDP-17. Nature 393: 702–705.
Schultz C, Dehghani F, Hubbard GB et al (2000) Filamentous tau pathology in nerve cells, astrocytes and oligodendrocytes of aged baboons. J Neuropathol Exp Neurol 59: 39–52.
Braak H, Braak E (1991) Demonstration of amyloid deposits and neurofibrillary changes in whole brain sections. Brain Pathol 1: 213–216.
Gallyas F (1971) Silver staining of Alzheimer’s neurofibrillary changes by means of physical development. Acta Morphol Acad Sci Hung 19: 1–8.
Mercken M, Vandermeeren M, Lübke U et al. (1992) Monoclonal antibodies with selective specificity for Alzheimer tau are directed against phosphatase-sensitive epitopes. Acta Neuropathol 84: 265–272.
Goedert M, Jakes R, Vanmechelen E (1995) Monoclonal antibody AT8 recognizes tau protein phosphorylated at both serine 202 and threonine 205. Neurosci Lett 189: 167–170.
Greenberg SG, Davies P, Schein JD et al. (1992) Hydrofluoric acid-treated tau/PHF proteins display the same biochemical properties as normal tau. J Biol Chem 267: 564–569.
Jicha GA, Lane E, Vincent I et al. (1997) A conformation-and phosphorylationdependent antibody recognizing the paired helical filaments of Alzheimer’s disease. J Neurochem 69: 2087–2095.
Schultz C, Koppers D, Sassin I et al. (1998) Cytoskeletal alterations in the human tuberai hypothalamus related to argyrophilic grain disease. Acta Neuropathol 96: 596–602.
Botez G, Probst A, Ipsen S et al. (1999) Astrocytes expressing hyperphosphorylated tau protein without glial fibrillary tangles in argyrophilic grain disease. Acta Neuropathol 98: 251–256.
Braak H, Braak E (1997) Frequency of stages of Alzheimer-related lesions in different age categories. Neurobiol Aging 18: 351–357.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2001 Springer Science+Business Media New York
About this chapter
Cite this chapter
Schultz, C., Hubbard, G.B., Del Tredici, K., Braak, E., Braak, H. (2001). Tau Pathology in Neurons and Glial Cells of Aged Baboons. In: Tolnay, M., Probst, A. (eds) Neuropathology and Genetics of Dementia. Advances in Experimental Medicine and Biology, vol 487. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-1249-3_5
Download citation
DOI: https://doi.org/10.1007/978-1-4615-1249-3_5
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-5461-1
Online ISBN: 978-1-4615-1249-3
eBook Packages: Springer Book Archive